Additional file 1 of Combining 1,4-dihydroxy quininib with Bevacizumab/FOLFOX alters angiogenic and inflammatory secretions in ex vivo colorectal tumors

Susan A. Kennedy, Maria E. Morrissey, Margaret R. Dunne, Fiona O’Connell, Clare T. Butler, , Amy M. Buckley, Brian J. Mehigan, John O. Larkin, Paul McCormick, Breandán N. Kennedy & Jacintha O’Sullivan
Additional file 1 Table S1. Patient characteristics including surgical details, and Tumor-Nodal-Metastasis (TNM) stage. The median age at the time of surgery 74.5 years (range: 62–82 years), with an equal number of males [4] & females [4]
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.